Characterization of aged osteocalcin fragments derived from bone resorption

Clinical Laboratory

Volumn 50, Issue 9-10, 2004, Pages 585-598

  Cloos, Paul A C ^a,b   Christgau, Stephan ^a,c  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b Biotech Research Innovation Centre ^*  (Denmark)

^c Nordic Bone   (Denmark)

Author keywords

Biochemical markers; Bone Gla protein; Bone turnover; Isomerization; Osteocalcin; Racemization

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; OSTEOCALCIN; ZOLEDRONIC ACID;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; BONE CELL; BONE MATRIX; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IN VITRO STUDY; MALE; MASS SPECTROMETRY; OSTEOLYSIS; PAGET BONE DISEASE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADULT; BONE AND BONES; BONE RESORPTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; OSTEOCALCIN; PEPTIDE FRAGMENTS;

EID: 4744341918     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Poser JW, Esch FS, Ling NC, Price PA 1980. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem 255: 8685-8691.
2. Price PA 1985. Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitamins Horm 42: 65-108.
3. Price PA, Williamson MK, Lothringer JW 1981. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256: 12760-12766.
4. Garnero P and Delmas PD 1998. Biochemical markers of bone turnover. Applications for osteoporosis Endocrinol Metab Clin North Am 27: 303-323.
5. Christgau S and Cloos PAC 2003. Current and future applications of bone turnover markers. Clin Lab 49: 439-446.
6. Rosenquist C, Bonde M, Fledelius C, Qvist P 1994. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 40: 1258-1264.
7. Kurihara N, Hosoda K, Tatsumi J, Yamaji T, Hoshihara E, Arai F, Ikeda K 1998. The N-terminal fragment of osteocalcin is released during osteoclastic bone resorption in vitro J Bone Miner Metab 16: 11-16.
8. Ivaska KK, Hellman J, Likojarvi J, Kakonen SM, Gerdhem P, Akesson K, Obrant KJ, Pettersson K, Kalervo Vaananen H 2003. Identification of novel proteolytic forms of osteocalcin in human urine. Biochem Biophys Res Commun 306: 973-80.
9. Srivastava AK, Mohan S, Singer FR, Baylink DJ 2002. A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients. Bone 31: 62-9.
10. Baumgrass R, Williamson MK, Price PA 1997. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Miner. Res 12: 447-455.
11. Matikainen T, Kakonen SM, Pettersson K, Karp M, Lovgren T, Vaananen H, Hellman J 1999. Demonstration of the predominant urine osteocalcin fragments detectable by two-site immunoassays. J Bone Miner Res 14: 431-8.
12. Novak JF, Hayes JD, Nishimoto SK 1997. Plasmin-mediated proteolysis of osteocalcin. J Bone Miner Res 12: 1035-1042.
13. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C 1994. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40: 2022-5.
14. Rosenqvist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, and Christiansen C. 1998. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 44: 2281-2289.
15. Foged NT, Delaissé J-M, Hou P, Lou H, Sato T, Winding B, and Bonde M 1996. Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Min Res 11: 226-237.
16. Rosenquist C, Qvist P, Bjarnason N, Christiansen C 1995. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 41: 1439-45.
17. Barkholt V, and Jensen AL 1989. Amino acid analysis: determination of cysteine plus half-cystine in proteins after hydrochloric acid hydrolysis with a disulfide compound as additive. Anal Biochem 177: 318-322.
18. Kramer A, Schuster A, Reineke U, Malin R, Volkmer-Engert R, Landgraf C and Schneider- Mergener J 1994. Combinatorial cellulose-bound peptide libraries: screening tool for the identification of peptides that bind ligands with predefined specificity. METHODS (Comp. Meth. Enzymol.) 6: 388-395.
19. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M 1992. Identification of osteopontin in isolated rabbit osteoclasts Biochem Biophys Res Commun 186: 911-917.
20. Fledelius C, Johnsen A, Cloos PAC, Bonde M, Qvist P 1997. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha 1) region. J Biol Chem 272: 9755-9763.
21. Murray ED Jr, Clarke S 1984. Metabolism of a synthetic L-isoaspartyl-containing hexapeptide in erythrocyte extracts. Enzymatic methyl esterification is followed by nonenzymatic succinimide formation. J Biol Chem 259: 10722-32.
22. Cloos PAC, Christgau S 2002. Non-enzymatic covalent modifications of proteins: mechanisms, physiological consequences and clinical applications. Matrix Biol 21: 39-52.
23. Bada JL 1984. In vivo racemization in mammalian proteins. Methods Enzymol. 106: 98-115.
24. Masters PM, Bada JL, Zigler JS Jr. 1977.Aspartic acid racemisation in the human lens during ageing and in cataract formation. Nature 268: 71-73.
25. Geiger and Clarke 1987. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem 262: 785-794.
26. Ritz S, Turzynski A, Schütz H-W, Hollmann A, and Rochholz G 1996. Identification of osteocalcin as a permanent aging constituent of the bone matrix: basis for an accurate age at death determination. Forensic Sci Int 770: 13-26.
27. Johnson BA, Aswad DW 1990. Fragmentation of isoaspartyl peptides and proteins by carboxypeptidase Y: release of isoaspartyl dipeptides as a result of internal and external cleavage. Biochem 29: 4373-80.
28. Cloos PAC and Christgau S 2003. Posttranslational modifications of proteins: Implications for aging, antigen recognition and autoimmunity. Biogerontology 5:139-58.